HIV Seroprevalence among High-Risk Groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a Behavioral Surveillance Survey
|
|
- Annabella Jefferson
- 6 years ago
- Views:
Transcription
1 AIDS Behav (2012) 16:86 90 DOI /s x ORIGINAL PAPER HIV Seroprevalence among High-Risk Groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a Behavioral Surveillance Survey Orang Ilami Bahador Sarkari Abdolmajid Khosravani Mehdi Akbartabar Tori Zahra Hosseini Published online: 29 December 2010 Ó Springer Science+Business Media, LLC 2010 Abstract We conducted a survey to assess the seroprevalence and risk behaviors for HIV infection in 2,009 individuals in Kohgiloyeh and Boyerahmad province, in Southwest of Iran. Blood samples were drawn from each participant and tested for anti-hiv1/2 antibodies. HIV antibodies were detected in 36 (1.8%) blood samples among a total of 2,009 participants. The rate of infection in inmates was 2.7% while this rate was 9.9% in injection drug users. Correlation between HIV infection and sex, age, marital status, history of imprisonment, injection drug use, and place of residence were significant. Improving of the surveillance in this community through supervision and monitoring of infected people is needed. Keywords Seroprevalence HIV High-risk group Prevalence Iran Introduction HIV is a challenging health problem in the new century. According to WHO report there were 33.4 million cases of HIV infection at the end of year 2008 and 2.7 million new O. Ilami A. Khosravani Z. Hosseini Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran B. Sarkari (&) Center of Basic Researches in Infectious Diseases, Shiraz University of Medical Sciences, Shiraz, Iran sarkarib@sums.ac.ir M. Akbartabar Tori Faculty of Health, Yasuj University of Medical Sciences, Yasuj, Iran cases of HIV have been reported in These reports show that there is an emerging incidence of HIV infection in Asia, the Indian subcontinent and a few of Middle East countries including Iran [1]. HIV-infected people serve as a reservoir for transmission of the infection to their partners and also other people including health care workers. It is essential to assess the magnitude of the problem in any region in each country. This will help the health authorities in improving the surveillance and prevention of the infection in the community through management and monitoring of infected individuals. In Iran, the infection is emerging mostly due to the problem of intravenous drug abuse and needle-sharing in the country. Iran has experienced two waves of the AIDS epidemic. The first wave was between 1986 and 1996, and those at risk of the epidemic were those who received contaminated blood or blood products. The second and new wave of the epidemic began within the last 15 years and the populations at risk have remained injection drug users and those who are engaged in unprotected sexual activities. More than 4.5 million people in Asia are estimated to inject drugs. Injection drug users (IDUs) constitute a large group of persons at high-risk for acquiring HIV infection [2]. The range of HIV infection in intravenous drug users in Iran has been reported to be over 10% and injecting drug users account for over two-thirds (67.5%) of reported HIV cases in Iran [3, 4]. HIV infection rates among high-risk groups are on the rise around the world. The high-risk populations for HIV infection are individuals who are involved in activities including blood transfusions, medical or dental practice, acupuncturing and tattooing, injection drug users, men who have sex with men (MSM), sex workers, prison inmates,
2 AIDS Behav (2012) 16: and health workers. HIV positive individuals might endanger their friends and families and also the general community to HIV infection. In this study we evaluated the epidemiological and behavioral characteristics of populations at a high-risk of HIV infection in high-risk groups in Kohgiloyeh and Boyerahmad province, southwest of Iran. Given the concentration of epidemic, the study was justified by the lack of information about HIV infection and HIV-related risk behavior in this area. Findings of this study might be used for better implementation of HIV surveillance and control programs not only in Iran but also in the region as it appears that the nature of the epidemic is similar across affected countries within the region. Materials and Methods The current study was conducted from 2009 to 2010 in Kohgiloyeh and Boyerahmad province. Kohgiloyeh and Boyerahmad is one of the 31 provinces of Iran. It is in the south west of the country (Fig. 1) and its capital is Yasuj. The province covers an area of 15,563 sq km, and in 2006 had a population of 634,000. The province is mostly mountainous in terrain, part of the Zagros range. High-risk groups for HIV in Iran (those who are involved in activities including blood transfusions, medical or dental practice, acupuncturing and tattooing, injection drug users, prison inmates, and health workers) were recruited for this study. After getting approval from the ethics committee of Yasuj University of Medical Sciences, blood samples were taken from 2,009 individuals at risk of HIV including, inmates, injection drug users, health care workers, patients on maintenance haemodialysis, hemophilic patients and people with a history of blood transfusion from Yasuj, Gachsaran, and Dehdasht (three main townships in the province). Participation in this study was voluntary and all participants were counseled about the study and they were requested to provide signed informed consent. Confidentiality of the details of the participants was guaranteed. A questionnaire was used to record the demographic features of participants during sample collecting. Moreover the questionnaire contained detailed questions concerning HIV-related risk behaviors such as intravenous drugs injection, history of imprisonment, having received blood and/or blood products, unsafe sexual activities, and history of other risk factors such as tattooing, body piercing, and history of surgery or dental practice. Five milli litres of blood was taken from each subject and sera were tested for anti-hiv1/2 antibodies, using an enzyme-linked immunosorbent assay (ELISA, DIALAB, Austria). Collected data were analyzed by SPSS version 13 software. Standard x 2 test was used to assess the correlation of demographic and behavioral variables and HIV seropositivity. Results Of 2,009 participants, 802 (39.9%) were from Yasuj, 803 (40%) were from Gachsaran and 404 (20.1%) were from Dehdasht Townships. Males constituted 66.4% of subjects whereas 33.4% of participants were female. Most of the subjects (39.6%) were in the age group years and majority of the study subjects were married (60.3%). Details of recruited high-risk groups are depicted in Table 1. HIV antibodies were detected in 36 (1.8%) of subjects. Rate of infection was higher in males (2.4%) compared to females (0.5%). The highest rate of infection (3.5%) was seen in Gachsaran Township. Rate of infection in inmates was 2.7% while this rate was 9.9% in injection drug users. The highest prevalence of HIV (3.2%); 15/472 was found Fig. 1 Location of Kohgiloyeh and Boyerahmad within Iran (Y Yasouj, D Dehdasht, G Gachsaran)
3 88 AIDS Behav (2012) 16:86 90 Table 1 High-risk groups and frequency of participant in each group High-risk groups Frequency Percent Inmates Health care workers Injection drug users Thalassemic Hemophilic History of transfusion Others a a Tattooing, history of surgery, dental practice, having HIV positive patients in the family Table 2 Risk factors associated with HIV infection in Kohgiloyeh and Boyerahmad province, southwest of Iran Risk factor in the years age group while no HIV infection was found in the 166 subjects 20 years or younger. Rate of infection was quite high (7.8%) in unemployed individuals. Health care workers constituted 0.6% of infected individuals. Table 2 represents the risk factors associated with HIV infection in this study. Correlation between HIV infection and sex, age, marital status, history of imprisonment, injection drug use, unprotected sex activities, level of education and place of residence were statistically significant (P \ 0.05). Multiple risk factors were noticed in some of the subjects and a significant correlation was found between the number of risk factors and positive HIV serostatus. Discussion HIV positive HIV negative Total P value History of P \ 0.05 imprisonment History of drug using P \ 0.05 History of transfusion P [ 0.05 History of needle stick P [ 0.05 Thalassemia P [ 0.05 Hemophilia P [ 0.05 Unprotected sex P \ 0.05 activities Others a P \ 0.05 a Tattooing, history of surgery, dental practice, having HIV positive patients in the family The Middle East stands as a region where knowledge of the epidemic continues to be very limited and subject to much controversy [5]. The cultural values in this region, in terms of prohibitions against premarital sex, homosexuality and alcohol and drug use, might contribute to a decline in the spread of HIV in this region. Nevertheless the recent data shows that the number of newly infected cases in these regions is increasing [1]. HIV infection rates among high-risk groups are on the rise in this region and around the world. The high-risk populations for HIV infection are those involved in activities such as blood transfusions, medical or dental practice, acupuncturing and tattooing, injection drug users, MSM sex workers, prison inmates, and health care workers. HIV positive individuals might put their friends and families as well as the general members of the community at risk of HIV infection. With the lack of data and information on the epidemiology of HIV in this area, the purpose of this study was to evaluate the seroprevalence of HIV and HIV-related risk behavior in high-risk groups in Kohgiloyeh and Boyerahmad province, southwest of Iran. Prevalence of HIV among all participants of this study was 1.8%. Findings of this study demonstrated that highrisk groups in Kohgiloyeh and Boyerahmad province are at great risk of HIV infection. Since the recruited subjects of this study are among the high-risk population, therefore the rate of HIV infection in the general population of the province might be different. Moreover, because of religious beliefs and the inconvenience of questions about sex behaviors, many individuals could not suitably answer these questions. Such data was not considered in statistical analysis. Self-reporting of behaviors such as sexual activity and drug use which resulted in underreporting of the risk factors are other limitations of this study. A significant correlation was found between sex and HIV infection where male were more likely to be infected than females. This is consistent with other studies in Iran and the rest of the region [6 8]. Considering the main route of HIV infection in Iran which is injecting drug use and the fact that the majority of IDU are males, the high rate of HIV infection in males is predictable. Higher rates of infection were found in Gachsaran in comparison with the other two townships. This might be due to the diversity of ethnic groups in this township and also to the geographical location of this township which is situated between three provinces with a relatively high trafficking of passengers. A correlation was found between imprisonment and HIV seropositivity. Similar connection has been shown in other studies in Iran. Rate of infection in prison inmates in the current study confirmed that the rate of HIV infection among inmates is relatively high. HIV infection in prison inmates might be a real challenge in controlling for HIV infection in the community since this group serves as a source of infection where they transfer the virus to their families upon release. The behavior of inmates that makes the HIV prevalence high among this population needs further investigation although
4 AIDS Behav (2012) 16: intravenous drug using might contributed to this high HIV prevalence. Findings of this study, as have been shown in previous studies, demonstrate a significant link between HIV infection and injection drug use [2]. In Rahimi-Movaghar [4] study in Tehran, prevalence of HIV was reported to be 10.7% in injecting drug users. Lower rate of HIV infection, however, has been reported in Imani [7] study in Shahr-e-Kord in intravenous drug users, where only one out of 1,333 IDU have been positive for HIV. Aceijas et al. [8] estimated that, in 2004, four of five IDUs worldwide lived in developing countries. The countries in which the majority of HIV infections have been attributed to injection drug use in 2005 included Russia, Ukraine, the central Asian republics, Iran, China, Indonesia, Nepal, and Vietnam. Although needle stick injury is a route of HIV infection and cases of HIV due to needle stick injury have been reported among health workers, our study shows no connection between a history of this route of transmission and HIV infection in health care workers. Receiving blood or blood products might endanger the recipient to HIV, although its probability in recent years is quite low with comprehensive testing of blood for HIV in blood transfusion centers. This study did not find a correlation between a history of blood transfusion and HIV infection. This is in keeping with the fact that nowadays the risk of transmission of HIV through blood or blood product is low. On the other hand, the rate of HIV infection in blood donors in Iran, which mainly voluntarily donate blood, is low. Khedmat et al. [9] reported a HIV prevalence of 0.003% (11 out of 318,029) for Iranian volunteer blood donors attending to Tehran blood transfusion service from 2005 to The prevalence of HIV in blood donors in neighboring countries is more or less the same. Khattak et al. [6] reported a prevalence of 0.007% for HIV in northern Pakistan in 103,858 blood donors. Thalassemic and hemophilic patients are at high-risk of acquiring HIV infection. No cases of HIV prevalence were found among the hemophilic and thalassemic patients in our study. This might be due to the low number of such cases in our study. Moreover, the risk of receiving contaminated blood is too low these days in many blood transfusions setting around the world as well as in Iran. Decrease in the rate of blood borne infection has been documented in Iran, e.g. for hepatitis C infection. It has been demonstrated that the prevalence of HCV in hemodialysis patients in Iran is decreasing from 14.4 in 1999 to 4.5% in 2006 [10]. Seroprevalence of HIV antibodies among multitransfused thalassemic and haemophiliac children in Shiraz was found to be zero (in 466 patients) and 0.36%, respectively [11, 12]. In Mirmomen study samples from patients with beta thalassemia from five provinces of Iran including Tehran, Kerman, Qazvin, Semnan and Zanjan were tested for HIV seropositivity. None of 732 samples were positive for HIV [12]. A consistent correlation was found between levels of education and HIV prevalence among the participants. Individuals with higher levels of education experience lower rates of infection. Individuals with relatively high levels of education are more likely to know how to prevent HIV infection and to take measures to protect themselves. In conclusion, findings of the present study provided epidemiologic features of HIV in Kohgiloyeh and Boyerahmad Province in Southwest of Iran and behavioral factors that characterize the epidemiology of HIV infection in the country. Moreover, findings of this study may help in improving the surveillance and prevention of the infection in the community through management and monitoring of infected individuals. Acknowledgments This study was financially supported by governor of Kohgiloyeh and Boyerahmad province. Authors would like to thank all of those who provided the blood samples for this study. References 1. UNAIDS epidemic update Available at: unaids.org/pub/report/2009/jc1700_epi_update_2009_en.pdf. 2. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375: Kheirandish P, Seyedalinaghi SA, Hosseini M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr. 2010;53: Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin- Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injection drug users in Tehran, Iran. Int J Infect Dis. 2010;14: Abu-Raddad LJ, Hilmi N, Mumtaz G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS. 2010; 24(Suppl 2):S Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002;52: Imani R, Karimi A, Rouzbahani R, Rouzbahani A. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. East Mediterr Health J. 2008;14: Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18: Khedmat H, Fallahian F, Abolghasemi H, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007;15: Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008;12:
5 90 AIDS Behav (2012) 16: Karimi M, Ghavanini AA. Seroprevalence of HBsAg, anti-hcv, and anti-hiv among haemophiliac patients in Shiraz, Iran. Haematologia (Budap). 2001;31: Mirmomen S, Alavian SM, Hajarizadeh B, et al. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med. 2006;9:
Assessment of hepatitis B in high risk people of Gachsaran city, Iran
International Journal of Research in Medical Sciences Khajavian M et al. Int J Res Med Sci. 27 Mar;(3):888-892 www.msjonline.org pissn 232-67 eissn 232-62 Original Research Article DOI: http://dx.doi.org/.823/232-62.ijrms2763
More informationEpidemiology of Hepatitis C Iran
Seyed Moayed Alavian M.D. Professor of Gastro & Hepatology Editor-in-chief of Glob Hepat Comm Editor-in-chief of Hepatitis Monthly E mail: editor@hepatmon.com Epidemiology of Hepatitis C Iran Epidemiology
More informationOverview of Blood Transfusion System of Iran:
Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationHot Topics in Tissue Safety
Hot Topics in Tissue Safety 37 th Annual AATB Meeting National Harbor, Maryland 03 October 2013 Scott A. Brubaker, CTBS Chief Policy Officer PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis
More informationHepatitis B is the most common cause of acute and chronic
Original Article Seroprevalence of Hepatitis B before Marriage: A Study on Marriage Candidates in the Southeast of Iran; Is It Worthy of Consideration? Mohammad Mehdi Hayatbakhsh MD 1, Sodaif Darvish Moghaddam
More informationOriginal article J Bas Res Med Sci 2017; 4(2):4-8.
Prevalence of HIV, hepatitis B and C infections among volunteer blood donors at the blood transfusion center of Ilam city, Iran Hasan Boustani 1, Enayat Anvari 2, Sedighe Saiadi Sartang 2, Mehdi Omidi
More informationModule 1: HIV epidemiology, transmission and prevention
Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C in Primary Care Presentation 2 January 2016 Quality Quality Education Education for for aa Healthier Healthier Scotland Scotland 1 1 Learning Outcomes Participants will be
More informationMedia centre. WHO Hepatitis B. Key facts. 1 of :12 AM.
1 of 5 2013-08-02 7:12 AM Media centre Hepatitis B Share Print Fact sheet N 204 Updated July 2013 Key facts Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic
More informationAIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia
ORIGINAL ARTICLE HIV/AIDS epidemic features and trends in Saudi Arabia Yagob Y. Al-Mazrou, PhD, FRCGP; Mohamed H. Al-Jeffri, MSc, DTM&H; Abdulla Ibrahim Fidail, DPH, MPH; Nasir Al-Huzaim, MPH, PhD; Sirrag
More informationThe Seroepidemiology of Hepatitis C Infection in Drug Abusers Referring to Shiraz Drug Rehabilitation Centers
Govaresh/ Vol. 21, No.3, Autumn 2016;188-193 The Seroepidemiology of Hepatitis C Infection in Drug Abusers Referring to Shiraz Drug Rehabilitation Centers Ramin Afshari 1, Mohammadreza Fattahi 2*, Masood
More informationCollege of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand
53 SOURCE OF INFORMATION AND KNOWLEDGE REGARDING TO HIV/AIDS AMONG STUDENTS OF BALOCHISTAN UNIVERSITY OF INFORMATION TECHNOLOGY AND MANAGEMENT SCIENCE QUETTA, PAKISTAN Sheh Mureed* and Prida Tasanapradit
More informationEpidemiology of blood-borne Infections in Vietnam
IPFA 4 th Asia Workshop on Plasma Quality and Supply Epidemiology of blood-borne Infections in Vietnam Nguyen Thị Lan Anh MD, PhD Center for Bio-Medical Rsearch Screening donated blood for infections:
More informationViral Hepatitis B and C in North African Countries
Viral Hepatitis B and C in North African Countries Prevalence, Risk factors and How to prevent Prof. Ossama Rasslan President, ESIC ICAN, Vice-Chair ICAN 2014, Harare, Zimbabwe, Nov 3rd 5th Overview Viral
More informationHepatitis B and human immunodeficiency viruses infection: awareness and universal precautions in Kassala, eastern Sudan
1315 Hepatitis B and human immunodeficiency viruses infection: awareness and universal precautions in Kassala, eastern Sudan Fatma Abbas 1, Tajeldin M. Abdallah 1, Mamoun Mgzoub 1, AbdelAziem A. Ali 1
More informationInjecting Drug Users: A Global Problem. Roger Detels, M.D., M.S.
Injecting Drug Users: A Global Problem Roger Detels, M.D., M.S. Global Areas of Drug User- Europe Transmitted HIV North America (U.S., Canada) South America Southeast Asia (Thailand, Myanmar, Vietnam,
More informationResearch Article Awareness of High School Students Regarding Modes of Spread and Complications of HIV/AIDS
Cronicon OPEN ACCESS MICROBIOLOGY Research Article Awareness of High School Students Regarding Modes of Spread and Complications of HIV/AIDS Khalid S Al-anzy, Saleh S Al-senani 2, Abdulaziz H Alazmi 2,
More informationUntil recently, countries in Eastern
10 C H A P T E R KNOWLEDGE OF HIV/AIDS TRANSMISSION AND PREVENTION Until recently, countries in Eastern Europe, the, and Central Asia had not experienced the epidemic levels of HIV/AIDS found in other
More information4th Asian Academic Society International Conference (AASIC) 2016 HEA-OR-095
HEA-OR-095 SITUATION ANALYSIS ON HIV PREVALENCE AMONG PWID IN VIETNAM Hoa Nguyen Institute Population and Social Research, Mahidol University, Thailand Corresponding author s email: nguyentunamkhanhhoa@gmail.com
More informationHepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.
What is Hepatitis? Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. Hepatitis A and E are not chronic and are mostly present in areas
More informationHepatitis Case Investigation
* indicates required fields Does patient also have: Hepatitis Case Investigation West Virginia Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology
More informationGroups at risk for hepatitis B infection - who should be vaccinated
Groups at risk for hepatitis B infection - who should be vaccinated male homosexuals heterosexuals with multiple sex partners (e.g. sex workers) travelers to areas of high HBV endemicity immigrants and
More informationHIV Infection, HIV/HCV and HIV/HBV co-infections among Jail Inmates of Lahore
Original Article HIV Infection, HIV/HCV and HIV/HBV co-infections among Jail Inmates of Lahore Muhammad Nafees 1, Akif Qasim 2, Ghazala Jafferi 3, Muhammad Saeed Anwar 4, Muhammad Muazzam 5 ABSTRACT Objective:
More informationHIV/AIDS Situation in Economic Cooperation Countries; Achievement and Gaps toward Millennium Development Goals
HIV/AIDS Situation in Economic Cooperation Countries; Achievement and Gaps toward Millennium Development Goals Ghobad Moradi; M.D. MPH 1, Hossein Malekafzali; M.D. Ph.D. 1, Kourosh Holakouie Naieni; Ph.D.
More informationResearch Article The Association of Hepatitis C Serological Status with Several Risk Factors in Indonesia
International Scholarly Research Notices Volume 2016, Article ID 3018135, 4 pages http://dx.doi.org/10.1155/2016/3018135 Research Article The Association of Hepatitis C Serological Status with Several
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationStudy on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran
Original Article Iran J Pediatr Jun 2010; Vol 20 (No 2), Pp:211-215 Study on Efficacy of Hepatitis B Immunization in Vaccinated Beta thalassemia Children in Tehran Zohreh Sharifi*, phd; Saeideh Milani,
More informationNew Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016
New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology
More informationHepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003
Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology
More informationBC Enhanced Hepatitis Strain Surveillance Project Hepatitis B. Acute HBV Questionnaire
BC Enhanced Hepatitis Strain Surveillance Project Hepatitis B Informed Consent: Please read to individual and answer any questions There are about 60,000 people with hepatitis B in BC. We want to find
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationRisk Factors Among People Living With HIV(PLWHIV)Attending Wad Medani VCT/ART Center, Gezira State, Sudan
Original article Risk Factors Among People Living With HIV(PLWHIV)Attending Wad Medani VCT/ART Center, Gezira State, Sudan Izzaddinn Elawad 1,Moawia Elbalal Mohammed, Hyder Osman Mirghani 3 1Assistant
More informationSEHAT-The Health Initiative
SEHAT-The Health Initiative Supported by: INDIA VISION FOUNDATION Presented by C. R. Garg Amrita Bahl Background HIV in India 1,065,070,607: Population of India (July 2004 est.) 5.1 million: Estimated
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationNotes Setting the Scene
We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationSeroprevalence of HCV Infection in the Residents of three Union Councils of Jamshoro District, Pakistan
International Journal of Emerging Trends in Science and Technology Seroprevalence of HCV Infection in the Residents of three Union Councils of Jamshoro District, Pakistan Authors ZulifqarAli Laghari 1,
More informationTrends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University
Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.
More informationAwareness regarding hepatitis B immunization among preclinical Indian dental students
Received: 29 Jun. 2013 Accepted: 8 Oct. 2013 Awareness regarding hepatitis B immunization among preclinical Indian dental students Amith Holenarasipur Vasanthakumar MDS 1, Audrey Madonna D Cruz MDS 2 Abstract
More informationThe Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
More informationSEROPREVALENCE OF ANTI-HCV ANTIBODIES AMONG VOLUNTARY BLOOD DONORS IN FATEHABAD DISTRICT OF HARYANA
SEROPREVALENCE OF ANTI-HCV ANTIBODIES AMONG VOLUNTARY BLOOD DONORS IN FATEHABAD DISTRICT OF HARYANA *Sangwan L., Arun P. 2 and Munjal A. 3 Haryana Civil Medical Service, Fatehabad, Haryana *Author for
More informationyour liver Care for Think about hepatitis
your liver Care for Think about hepatitis World Hepatitis Day 2015 What is hepatitis? Hepatitis is the common name for all inflammatory diseases of the liver. Liver inflammation is most often caused by
More informationAIDS in Developing Countries
AIDS in Developing Countries MODES OF TRANSMISSION Blood Semen/genital secretions Vertical RISK ACTIVITIES THAT PROMOTE TRANSMISSION OF HIV Receiving blood contaminated with HIV Being born to an HIV-infected
More informationEpidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)
Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) At a Glance Reported rates of acute HCV declined from.5 per, population in to.
More informationWe need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles
0 We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationaids in asia and the pacific
HIV AIDS AND DEVELOPMENT IN ASIA AND THE PACIFIC a lengthening shadow aids in asia and the pacific World Health Organization Regional Offices for South East Asia and the Western Pacific Region 9 10 OCTOBER
More informationThe new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationCurrent Infectious Disease Screening for the Live Organ Donor
2013 Public Health and Safety Guidelines for reducing HIV, HBV and HCV Transmission Though Organ Transplantation: Implications for Counseling and Disclosure Dianne LaPointe Rudow DNP, ANP-BC, CCTC Director
More informationHIV SCREENING WORKSHOP Exercise
HIV SCREENING WORKSHOP Exercise INTRODUCTION: Since its first discovery in 1981, AIDS became a pandemic. Worldwide, actually over 30 million people are living with HIV (i.e., are infected by the human
More informationHIV, STI AND OTHER BLOOD- BORNE DISEASES. Kolářová M., EPI Autumn 2015
HIV, STI AND OTHER BLOOD- BORNE DISEASES Kolářová M., EPI Autumn 2015 Chlamydia infection Genital warts Gonorrhoea Hepatitis B Hepatitis C HIV infection and AIDS Human papillomavirus infection Sexually
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More informationEpidemiology of hepatitis B in The Netherlands
Viral Hepatitis Prevention Board Meeting Rotterdam, The Netherlands, November 13-14, 2008 National Institute for Public Health and the Environment Epidemiology of hepatitis B in The Netherlands Mirjam
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationViral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
More informationHIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA
HIV/AIDS in China -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA September 12, 2008 1 HIV epidemic in Asia General Population
More informationHIV/AIDS MODULE. Rationale
HIV/AIDS MODULE Rationale According to WHO HIV/AIDS remains one of the world's most significant public health challenges, particularly in low- and middle-income countries. As a result of recent advances
More informationPREVALENCE OF VIRAL INFECTIONS AMONG THE DRUG ADDICTS IN LIBYA
PREVALENCE OF VIRAL INFECTIONS AMONG THE DRUG ADDICTS IN Ibrahim, M. Ghariba Higher Institute for Comprehensive Professions, Mizdah, Libya Tamalli, M Faculty of Science, Al-margeb University, Libya Alghazal
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationResearch Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario
e Scientific World Journal, Article ID 173939, 4 pages http://dx.doi.org/10.1155/2014/173939 Research Article Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario Tulika Chandra,
More informationChiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT
Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT David Celentano, Professor of Epidemiology May 26, 2005 Scope of the CMU/JHU Collaborative HIV/AIDS Research Agenda HIV/AIDS research
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES
ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES David Njabulo Whiters, PhD, MSW, NCAC II Consultant, Great Lakes Addiction Technology Transfer Center Setting
More informationSeroprevalence of Hepatitis B Surface Antigen (HBsAg) Among Patients at a Tertiary Care Hospital in Mumbai, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 4 (2017) pp. 722-726 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.604.088
More informationELPA S VISION OF SCREENING
ELPA S VISION OF SCREENING By Nadine Piorkowsky President of the European Liver Patients Association, Budapest, 18-19 March 2010 ELPA s network The Patient s View a viral time bomb: Up to 9 out of 10 chronic
More informationSIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/13 Provisional agenda item March Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY A67/13 Provisional agenda item 12.3 28 March 2014 Hepatitis Improving the health of patients with viral hepatitis Report by the Secretariat 1. The Executive Board at
More informationiphis Case ID #: Reported Date: Reporting Source: Diagnosing Health Unit: Branch Office: Outbreak Number:
Case Investigation Form: Hepatitis C Legend iphis system mandatory Required Case Information (add dates as YYYY-MM-DD) Case s Last Name: Case s First Name: Middle Name: Birth Date: Male Gender: Female
More informationPREVENTION OF HEPATITIS B; KNOWLEDGE AND PRACTICE AMONG FIRST YEAR MBBS STUDENTS
PREVENTION OF HEPATITIS B 634 ORIGINAL PROF-1264 PREVENTION OF HEPATITIS B; KNOWLEDGE AND PRACTICE AMONG FIRST YEAR MBBS STUDENTS DR. SEEMA DAUD Associate Professor & Head DR. IRAM MANZOOR Assistant Professor
More informationSyringe type and HIV risk: current knowledge and future directions
Syringe type and HIV risk: current knowledge and future directions Presented by William A. Zule, Dr.PH Along with Georgiy V. Bobashev, Curtis M. Coomes, Don C. Des Jarlais, Samuel R. Friedman, V. Anna
More informationHepatitis B Virus and the Opioid Crisis
Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers
More informationDigestive & Liver Disease Wellness
Digestive & Liver Disease Wellness Colorectal Cancer Screening & Prevention According to the American Cancer Society, this year 136,830 people in the U.S. According will be to diagnosed the American with
More informationShould Methadone and/or Buprenorphine be included in the WHO Model List of Essential Medicines? Reviewing evidence from Iranian experience.
Should Methadone and/or Buprenorphine be included in the WHO Model List of Essential Medicines? Reviewing evidence from Iranian experience. MT Yasamy, MD * Essential drugs are those that satisfy the health
More information26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges
Rate per, Types of Viral Hepatitis A E B D C Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Source of virus Feces Feces Blood/bloodderived body fluids
More informationComparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Jamalidoust et al. Virology Journal (2017) 14:127 DOI 10.1186/s12985-017-0797-2 RESEARCH Open Access Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit
More informationEvaluation of Hepatitis B Infection Prevalence in Institutionalized Intellectually Disabled Children
Novelty in Biomedicine Original Article Evaluation of Hepatitis B Infection Prevalence in Institutionalized Intellectually Disabled Children Foad Davoodbeglou, Mehrnaz Mesdaghi, Hossein Goudarzi, Fariba
More informationEpidemiology of HCV infection among HD pts in Iran and prevention strategies
Epidemiology of HCV infection among HD pts in Iran and prevention strategies B. Einollahi Professor of Internal Medicine/Nephrology Division Baqiyatallah University of Medical Sciences 4th International
More informationth MARCH 2011 Women can transmit HIV to their babies during pregnancy or birth, when infected maternal cells enter the baby's circulation.
HIV/AIDS Overview th NATIONAL HIV/AIDS WORKSHOP FOR PARA-MEDICS ON 11 th -12 th MARCH 2011 HIV (human immunodeficiency virus) infection has now spread to every country in the world. Approximately 40 million
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationJMSCR Vol 3 Issue 10 Page October 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x DOI: http://dx.doi.org/10.18535/jmscr/v3i10.12 Seroprevalance of Hepatitis B and Hepatitis C Virus Infection among HIV Positive Individuals
More informationBiological Forum An International Journal 8(1): (2016)
Biological Forum An International Journal 8(1): 460-465(2016) ISSN No. (Print): 0975-1130 ISSN No. (Online): 2249-3239 Epidemiological and Clinical Features of HIV/AIDS Patients Attending to the National
More informationDetection of Hepatitis B and C in Primary Care
Detection of Hepatitis B and C January 2014 Quality Education for a Healthier Scotland 1 Learning Outcomes Participants will be able to:- Identify groups of people who have a higher prevalence of Hepatitis
More informationX-Plain Hepatitis B Reference Summary
X-Plain Hepatitis B Reference Summary Introduction Hepatitis B is the most common serious liver infection. It is caused by the hepatitis B virus that attacks the liver. The virus is transmitted through
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationJMSCR Volume 03 Issue 01 Page January 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Seroprevalence of HBV among HIV Patients and Blood Donors Author Dr. Vedavati B I 1, Dr. Amrutha Kumari B 2, Dr. Venkatesha D 3 Mysore
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationPrevention of Hepatitis in risk groups and hepatitis and HIV in Albania. Ass.Prof. Najada COMO
VHPB Meeting Prevention of Hepatitis in risk groups and hepatitis and HIV in Albania Ass.Prof. Najada COMO Infectious Diseases Clinic UHC Mother Theresa Tirane Rogner, Tirane, Albania, 27 28 October 2016
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationDHQ v2.0, February 2016 Table Detailing Changes from v1.3 v1.3 Revised language in v2.0 Rationale Question 1: Are you
DHQ v2.0, February 2016 Table Detailing s from v1.3 v1.3 Revised language in v2.0 Rationale Question 1: Are you Q 1, No Feeling healthy and well today? Question 2: Are you Q 2, No change Currently taking
More informationEpidemiology of AIDS and HIV Infection in the Caribbean
Epidemiology of AIDS and HIV Infection in the Caribbean JAI I? NARAIN,* B. HULL,* C. J. HOSPEDALES,~ S. MAHABIR,~ & D. C. BASSETT~ S A review of surveillance data on AIDS and HIV infection in the 18 English-speaking
More informationNIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:
ABC s of Hepatitis C Treatment Today Elizabeth N. Britton, MSN, FNP-BC Hepatology Services Louisiana State University Health Sciences Center ebritt@lsuhsc.edu ANAC CONFERENCE -TUCSON NOV 2012 Hepatitis
More informationHEPATITIS B INFECTION and Pregnancy. Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011
HEPATITIS B INFECTION and Pregnancy Caesar Mensah Communicable Diseases & Infection Control Specialist, UK June 2011 HEPATITIS B 26/07/2011 What is Hepatitis B? It is inflammation (infection) of the liver
More informationSEROLOGICAL SURVEY OF VIRAL HEPATITIS A, B, AND C AT THAI CENTRAL REGION AND BANGKOK: A POPULATION BASE STUDY
SEROLOGICAL SURVEY OF VIRAL HEPATITIS A, B, AND C AT THAI CENTRAL REGION AND BANGKOK: A POPULATION BASE STUDY Winai Ratanasuwan 1, Areeua Sonji 1, Surapee Tiengrim 2, Wichai Techasathit 1 and Surapol Suwanagool
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationNotes Detection of Hepatitis B and C in Primary Care
Health Protection Scotland/NHS Education Scotland January 2016 Injecting drug use is the commonest route of transmission in Scotland and the UK. Sharing of any of the equipment used to inject drugs can
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationHepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre
Hepatitis B Introduction Hepatitis B virus is one of the most prevalent viruses worldwide and is a major cause of chronic liver disease and hepatocellular carcinoma. It is a hepadnavirus, consisting of
More informationkeyword: hepatitis Hepatitis
www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,
More informationIndian Journal of Basic and Applied Medical Research; June 2016: Vol.-5, Issue- 3, P
Original article: Comparative study on Prevalence of Hepatitis B surface antigen among blood donors and In patient hospital attendees at a tertiary care hospital, Hyderabad. 1Dr M. Khaleel, 2 Dr Ameena
More information